MetLife director granted 721 shares of stock

Seitz Michelle reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Seitz Michelle reported acquisition or exercise transactions in this Form 4 filing.

METLIFE INC director Michelle Seitz received a grant of 721 shares of Common Stock as part of her board compensation. The shares were awarded at a stated price of $0.00 per share as a non-management director retainer paid in MetLife common stock. Following this award, she holds 994 shares directly.

Insider Trade Summary

Grant/Award: 721 shares

Grant/Award 1 txn

Insider Seitz Michelle

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$0.00	$0.00

Holdings After Transaction: Common Stock — 994 shares (Direct)

Footnotes (1)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Key Figures

Shares granted: 721 shares Price per share: $0.00 per share Shares held after grant: 994 shares

3 metrics

Shares granted 721 shares Common Stock grant on 2026-04-01

Price per share $0.00 per share Stated grant price for director award

Shares held after grant 994 shares Total direct holdings following transaction

Key Terms

non-management director compensation arrangements, retainer fees, Grant, award, or other acquisition

3 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion..."

retainer fees financial

"director retainer fees in MetLife, Inc. common stock."

Grant, award, or other acquisition financial

"transaction code description is Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MET director Michelle Seitz report?

Michelle Seitz reported receiving 721 shares of MetLife Common Stock as a compensation grant. The shares were awarded at a stated price of $0.00 per share and increased her direct holdings to 994 shares following the transaction, according to the Form 4 filing.

Was the MET Form 4 transaction a market purchase or a stock grant?

The transaction was a stock grant, not a market purchase. It reflects MetLife’s non-management director compensation, where a portion of retainer fees is paid in MetLife common stock rather than cash, resulting in 721 new shares awarded to director Michelle Seitz.

How many MET shares does Michelle Seitz hold after this Form 4 transaction?

After the grant, Michelle Seitz directly holds 994 shares of MetLife Common Stock. This total reflects the addition of 721 shares awarded as part of her non-management director retainer, as disclosed in the Form 4 insider transaction report.

What does the footnote say about MetLife (MET) director compensation?

The footnote explains that MetLife’s non-management director compensation arrangements pay a portion of director retainer fees in MetLife common stock. This structure leads to periodic stock awards, like the 721-share grant reported by director Michelle Seitz on the Form 4.

Does the MET Form 4 indicate any stock sales by Michelle Seitz?

The Form 4 shows only an acquisition of shares through a grant and no sales. It reports one transaction coded as a grant or award acquisition, increasing Michelle Seitz’s direct holdings to 994 MetLife Common Stock shares with no dispositions listed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Seitz Michelle

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$0	994	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)